{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:27:46Z","timestamp":1748363266276,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.heliyon.2021.e08265","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T05:24:26Z","timestamp":1635398666000},"page":"e08265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ocular toxoplasmosis in immunocompetent adults: current cost-effectiveness of four treatment regimens in Colombia"],"prefix":"10.1016","volume":"7","author":[{"given":"Valentina","family":"\u00c1lvarez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Rubio-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Alejandra","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"G\u00f3mez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-1989","authenticated-orcid":false,"given":"Alejandra","family":"de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12-13","key":"10.1016\/j.heliyon.2021.e08265_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09273948.2010.605198","article-title":"Review of the series \u201cdisease of the year 2011: toxoplasmosis\u201d pathophysiology of toxoplasmosis","volume":"19","author":"Subauste","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"9-10","key":"10.1016\/j.heliyon.2021.e08265_bib3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.micinf.2006.03.023","article-title":"Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America)","volume":"8","author":"Peyron","year":"2006","journal-title":"Microb. Infect."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e08265_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment","volume":"136","author":"Holland","year":"2003","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08265_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.25100\/cm.v26i.2.1745","article-title":"Toxoplasmosis congenita en Colombia: un problema subestimado de salud p\u00fablica","volume":"26","author":"G\u00f3mez-Mar\u00edn","year":"2014","journal-title":"Colomb. M\u00e9d."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08265_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/09273948.2011.582220","article-title":"Quality of life assessment in ocular toxoplasmosis in a Colombian population","volume":"19","author":"de-la-Torre","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08265_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/09273948.2019.1612453","article-title":"Quality-of-Life and psychosocial aspects in patients with ocular toxoplasmosis: a clinical study in a tertiary care hospital in Brazil","volume":"28","author":"Canamary","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"year":"2015","series-title":"Infecci\u00f3n por toxoplasma: panorama actual. Spei Domus [Internet]","author":"Palmezano D\u00edaz","key":"10.1016\/j.heliyon.2021.e08265_bib8"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/eye.2008.219","article-title":"Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis","volume":"23","author":"De-la-Torre","year":"2009","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09273948.2011.608915","article-title":"Therapy for ocular toxoplasmosis","volume":"19","author":"De-La-Torre","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib11","first-page":"549","article-title":"The risks of pyrimethamine-sulfadoxine combination in the prenatal treatment of toxoplasmosis","volume":"21","author":"Dorangeon","year":"1992","journal-title":"J.\u00a0Gynecol. Obstet. Biol. Reprod. (Paris)"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib12","first-page":"13","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08265_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.reprotox.2005.10.006","article-title":"Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection","volume":"21","author":"Rorman","year":"2006","journal-title":"Reprod. Toxicol. Elmsford N."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08265_bib14","first-page":"116.e1","article-title":"The Spanish society of pediatric infectious diseases guidelines for the diagnosis and treatment of congenital toxoplasmosis","volume":"79","author":"Baquero-Artigao","year":"2013","journal-title":"Pediatria"},{"issue":"8","key":"10.1016\/j.heliyon.2021.e08265_bib15","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1128\/JCM.41.8.3537-3541.2003","article-title":"Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis","volume":"41","author":"Villard","year":"2003","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1099\/0022-1317-50-1-62","article-title":"Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis","volume":"50","author":"Suzuki","year":"2001","journal-title":"J.\u00a0Med. Microbiol."},{"year":"2015","series-title":"Clinical Immunology: Principles and Practice. S.l.: Elsevier\/Saunders","author":"Fleisher","key":"10.1016\/j.heliyon.2021.e08265_bib18"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib19","first-page":"1","article-title":"Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management","volume":"137","author":"Holland","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM198802043180509","article-title":"Toxoplasmosis: the time has come","volume":"318","author":"McCabe","year":"1988","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e08265_bib21","unstructured":"Cancino E, Fontib\u00f3n M, Le\u00f3n H, El Tunal M, Ot\u00e1lora R, Suba M, et\u00a0al. Secretar\u00eda Distrital de Salud de Bogot\u00e1, DC Asociaci\u00f3n Bogotana de Obstetricia y Ginecolog\u00eda (Asbog). Gu\u00eda Control Prenat Factores Riesgo."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08265_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.iac.2015.07.001","article-title":"Overview of immunodeficiency disorders","volume":"35","author":"Raje","year":"2015","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10815-010-9413-8","article-title":"Using decision trees to enhance interdisciplinary team work: the case of oncofertility","volume":"27","author":"Gardino","year":"2010","journal-title":"J.\u00a0Assist. Reprod. Genet."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e08265_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jval.2019.01.014","article-title":"Real-world evidence in Healthcare decision making: global trends and case studies from Latin America","volume":"22","author":"Justo","year":"2019","journal-title":"Value Health"},{"year":"2021","series-title":"TERM\u00d3METRO DE PRECIOS DE MEDICAMENTOS [Internet]","author":"Ministerio de Salud y Protecci\u00f3n Social","key":"10.1016\/j.heliyon.2021.e08265_bib25"},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08265_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.heliyon.2021.e08265_bib28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","article-title":"Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis","volume":"112","author":"Soheilian","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heliyon.2021.e08265_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ajo.2016.08.003","article-title":"Trimethoprim-sulfamethoxazole versus placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences: a three-year follow-up","volume":"170","author":"Fernandes Felix","year":"2016","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08265_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08265_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9394(00)00830-8","article-title":"A\u00a0follow-up study of Toxoplasma gondii infection in southern Brazil","volume":"131","author":"Silveira","year":"2001","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10792-012-9634-1","article-title":"Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial","volume":"33","author":"Baharivand","year":"2013","journal-title":"Int. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08265_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08265_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0123-9392(13)70163-2","article-title":"Cost effectiveness of various diagnostic strategies for detecting congenital toxoplasmosis in newborns","volume":"17","author":"Chica\u00edza-Becerra","year":"2014","journal-title":"Infection"},{"year":"2014","series-title":"Manual \u00fanico para la calificaci\u00f3n de la p\u00e9rdida de la capacidad laboral y ocupacional [Internet]. Decreto 1507","author":"Ministerio de Trabajo","key":"10.1016\/j.heliyon.2021.e08265_bib35"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib36","article-title":"Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study. Ngondi JM, editor","volume":"10","author":"Aleixo ALQ do","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08265_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01964427","article-title":"Efficacy of pyrimethamine\/sulfadoxine in the prevention of toxoplasmic encephalitis relapses andPneumocystis carinii pneumonia in HIV-infected patients","volume":"12","author":"Ruf","year":"1993","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08265_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.joco.2016.10.002","article-title":"A\u00a0prospective randomized trial of azithromycin versus trimethoprim\/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis","volume":"29","author":"Lashay","year":"2017","journal-title":"J.\u00a0Curr. Ophthalmol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021023689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021023689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:59:58Z","timestamp":1736488798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021023689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2405844021023689"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08265","relation":{},"ISSN":["2405-8440"],"issn-type":[{"type":"print","value":"2405-8440"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular toxoplasmosis in immunocompetent adults: current cost-effectiveness of four treatment regimens in Colombia","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e08265"}}